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Abstract
Introduction Consistent data about the incidence and outcome of sepsis in Latin American intensive care units
(ICUs), including Brazil, are lacking. This study was designed to verify the actual incidence density and outcome of
sepsis in Brazilian ICUs. We also assessed the association between the Consensus Conference criteria and outcome
Methods This is a multicenter observational cohort study performed in five private and public, mixed ICUs from two
different regions of Brazil. We prospectively followed 1383 adult patients consecutively admitted to those ICUs from
May 2001 to January 2002, until their discharge, 28th day of stay, or death. For all patients we collected the following
data at ICU admission: age, gender, hospital and ICU admission diagnosis, APACHE II score, and associated
underlying diseases. During the following days, we looked for systemic inflammatory response syndrome (SIRS),
sepsis, severe sepsis, and septic shock criteria, as well as recording the sequential organ failure assessment score.
Infection was diagnosed according to CDC criteria for nosocomial infection, and for community-acquired infection,
clinical, radiological and microbiological parameters were used.
Results For the whole cohort, median age was 65.2 years (49–76), median length of stay was 2 days (1–6), and the
overall 28-day mortality rate was 21.8%. Considering 1383 patients, the incidence density rates for sepsis, severe
sepsis and septic shock were 61.4, 35.6 and 30.0 per 1000 patient-days, respectively. The mortality rate of patients
with SIRS, sepsis, severe sepsis and septic shock increased progressively from 24.3% to 34.7%, 47.3% and 52.2%,
respectively. For patients with SIRS without infection the mortality rate was 11.3%. The main source of infection was
lung/respiratory tract.
Conclusion Our preliminary data suggest that sepsis is a major public health problem in Brazilian ICUs, with an
incidence density about 57 per 1000 patient-days. Moreover, there was a close association between ACCP/SCCM
categories and mortality rate.
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Introduction
Consistent data about the incidence and outcome of sepsis in
Latin American intensive care units (ICUs), including Brazil, are
lacking. In general, local registries consider sepsis as an
admission diagnosis only, and do not identify those patients
who develop sepsis during their ICU stay. Furthermore, the
behavior of sepsis and sepsis-related organic dysfunction has
not been established outside the developed countries. Mainly
for economic reasons, there are no consistent epidemiological
data that would allow adequate investigational, preventive or
even corrective strategies with regard to this problem.
Brazil is a country of continental dimensions with a heteroge-
neous population and unequal access to health services. Pri-
vate hospitals are usually better equipped and have more
resources than public hospitals, with the exception of some
public university hospitals. Measures to diminish the preva-
lence of sepsis and to reduce sepsis-related mortality driven
by reliable data about sepsis in the population of Brazil should
be included in any national health programs.
During the past decade there has been a host of discoveries
about sepsis pathogenesis, prevention and therapeutic strate-
gies [1-3]. However, sepsis prevalence and mortality rates
remain extremely high [4-7]. Angus and colleagues [5] esti-
mated the incidence of severe sepsis to be 751,000 cases per
year in the USA, which corresponds to 3.0 cases per 1000
inhabitants and 2.26 cases per 100 hospital discharges. The
observed overall mortality rate was 28.6%. In a large, prospec-
tive European epidemiological study, Alberti and colleagues
[6] evaluated 14,364 patients admitted to 28 ICUs. Their main
findings were a crude infection incidence of 21.1%, and in ICU
patients hospitalized longer than 24 hours an infection inci-
dence of 18.9%, including 45% of patients already infected at
ICU admission. About 24% of infections were associated with
severe sepsis and 30% with septic shock. Total hospital mor-
tality rates ranged from 16.9% in non-infected patients to
53.6% in patients with hospital-acquired infections. More
recently, a multicenter French study [7] has shown a high inci-
dence of septic shock (8.2 per 100 admissions) among criti-
cally ill patients associated with a high crude mortality rate
(60.1%).
Although some randomized clinical trials [2,8] have used the
American College of Chest Physicians/Society of Critical
Care Medicine (ACCP/SCCM) Consensus Conference crite-
ria [9] there are a few prospective cohort studies [6,10]
addressing the actual incidence of sepsis, severe sepsis and
septic shock based on those criteria. Furthermore, despite the
putative capacity of ACCP/SCCM categories to discriminate
the severity of illness and related mortality, they do not provide
a dynamic measurement of organ dysfunction development
and outcome. A simultaneous daily use of organ dysfunction
descriptors might therefore be useful to better characterize in-
ICU progress and estimate the severity of patients' condition
daily.
In this study we prospectively analyzed all patients admitted to
five mixed ICUs with different characteristics, located in two
distinct Brazilian regions, to determine the actual incidence
density of sepsis. Additionally, we assessed the association
between the severity categories of the Consensus Confer-
ence criteria and outcomes.
Methods
Study design and setting
This was a multicenter observational cohort study conducted
from May 2001 to January 2002, involving all adult patients
admitted consecutively to five mixed ICUs in two different
regions of Brazil: Hospital Israelita Albert Einstein (a private
tertiary hospital), Hospital Geral do Grajaú (a public commu-
nity hospital managed by a private university), Hospital Gover-
nador Celso Ramos (a public tertiary hospital and regional
trauma center), University Hospital of the Federal University of
Santa Catarina (a public university hospital), and Hospital do
Servidor Público of the State of São Paulo (a public tertiary
teaching hospital). The detailed characteristics of each hospi-
tal, such as number of hospital and ICU beds, mean monthly
hospital and ICU admissions, and mean ICU length of stay
(LOS) are shown in Table 1.
Subjects
All patients were admitted to the ICUs during the study period.
Patients less than 18 years old or transferred from other hos-
pitals were excluded from the study. Patients without informed
consent were not included.
Measurements and outcome evaluation
Complete data for all patients admitted to the ICUs were
obtained until their ICU discharge, 28th day of stay, or death.
Mortality status was obtained for all patients at the 28th day
after inclusion in the study. For patients who stayed less than
24 hours in the ICU, we recorded only their demographic data,
ICU diagnosis (according to admission categories defined in
the Acute Physiology and Chronic Health Evaluation II
[APACHE II], which included sepsis) and outcome. For
patients with a LOS greater than 24 hours, on admission to the
ICU (day zero) the age, gender, hospital and ICU admission
diagnoses, APACHE II score, and associated underlying dis-
eases were noted. Additionally, systemic inflammatory
response syndrome (SIRS), sepsis, severe sepsis and septic
shock criteria, as well as sequential organ failure assessment
(SOFA) score [11] were evaluated daily. For calculation of
APACHE II and SOFA scores, all laboratory and clinical data
not measured were considered to be within normal ranges. For
those variables that do not change acutely (such as bilirubin
and creatinine concentrations) and were not measured on a
specific day, we assumed the closest value from the previous
day. The neurological status of patients receiving sedativeAvailable online http://ccforum.com/content/8/4/R251
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drugs was assessed by the Glasgow Coma Scale as meas-
ured or estimated before sedation.
A single patient might have contributed to more than one sur-
veillance episode, if he or she were admitted more than once
to the ICU during his or her hospitalization period. The onset
of sepsis, severe sepsis or septic shock was defined as the
time at which screening and confirmatory criteria were first
documented.
Definitions
Sepsis and sepsis-related conditions were diagnosed in
accordance with the criteria proposed by ACCP/SCCM [6],
as follows.
SIRS was defined by two or more of the following criteria: tem-
perature above 38°C or below 36°C, tachycardia (heart rate
more than 90 beats/min), tachypnoea manifested by a raised
respiratory rate (more than 20 breaths/min) or hyperventilation
(partial pressure of CO2 in arterial blood < 32 mmHg) or
mechanical ventilation, altered white blood cell count (more
than 12,000/mm3, less than 4000/mm3 or more than 10% of
band forms).
Sepsis was defined as a systemic inflammatory response due
to infection.
Severe sepsis was defined as sepsis plus at least one organ
dysfunction according to the SOFA score. Any value of the
SOFA score ascribed for organ dysfunction defined a patient
as having severe sepsis.
Septic shock was defined as severe sepsis and vasoactive
drug requirement (SOFA 3–4).
The diagnosis of community-acquired infection was based on
clinical, image and microbiological parameters. As directed by
the attending physician, blood, tracheal secretion, urine,
Table 1
Hospital and demographic characteristics for participating centers
Characteristic Hospital Albert 
Einstein
Hospital Geral do 
Grajaú
Hospital 
Governador Celso 
Ramos
Hospital 
Universitário da 
UFSC
Hospital dos 
Servidores do 
Estado de SP
(Center 1) (Center 2) (Center 3) (Center 4) (Center 5)
Type Private tertiary 
hospital
Public community 
hospital managed 
by a private 
university
Public tertiary 
hospital with a 
regional trauma 
center
Public University 
hospital
Public tertiary 
teaching hospital
Number of beds 400 249 272 255 391
Number of ICU beds 28 12 12 06 16
S t e p d o w n  u n i tY e s N oN oN oN o
Mean monthly hospital 
admissions
1400 1050 503 624 2184
Mean monthly ICU 
admissions
170 38 46 25 103
Enrollment period 21 May to 10 
October 2001
21 May to 10 
October 2001
21 May to 10h 
October 2001
21 May to 10 
October 2001
1 November to 31 
January 2002
Overall
Number of ICU admissions 837 194 228 124 305 1688
Number of excluded patients 100 02 07 10 13 132
Number of missed patients 134 11 02 12 14 173
Number of enrolled patients 603 181 219 102 278 1383
Ratio of >24 h patients to all 
patients
0.59 0.80 0.57 0.75 0.64 0.64
Mean ICU LOS, days 1 (1–4) 4 (2–9) 2 (1–7) 2 (1–6) 2 (1–6) 2 (1–6)
Overall ICU mortality rate,% 11.6 38.25 27.7 28.7 26.1 21.8
ICU, intensive care unit; LOS, length of stay. Figures in parentheses are interquartile ranges.Critical Care    August 2004  Vol 8 No 4    Silva et al.
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cerebrospinal fluid and wound/skin secretion samples were
obtained for culture. For nosocomial infection, the diagnosis
was based on the definitions of the Centers for Disease Con-
trol [12]. The infection source was classified by the attending
physician as lung/respiratory tract, urine, primary bloodstream
or wound/surgical site.
After the cohort had been identified, two study groups were
determined: patients with an ICU LOS of less than 24 hours,
and patients with an ICU LOS of more than 24 hours. We have
included data from the first group to obtain an overview of ICU
profile (Table 1). The incidence density and mortality rates of
sepsis were calculated from the total number of patients
enrolled in the study (n = 1383). We also calculated the inci-
dence density of SIRS, sepsis, severe sepsis and septic shock
in patients in the second group (n = 884). In addition, we com-
pared epidemiological data between private and public hospi-
tals (center 1 versus other centers).
Sepsis-related mortality was defined as death due to a septic
event, in accordance with the investigator's judgment.
In each participating center, physicians and research nurses
were trained to collect data; a coordinator research nurse val-
idated those data. A coordinating center (Hospital Israelita
Albert Einstein) supported data registration at each center,
and all data were checked to be within acceptable ranges.
Every clinical report form was therefore checked for blank
fields or obvious errors. Whenever present, exception reports
were returned to each center for immediate correction. A sub-
set of about 10% (n = 130) of all clinical report forms were
cross-checked with original patient charts to test data validity.
Most of them were considered adequate. An operating manual
defined all collected variables precisely.
The institutional review boards of all participating centers
approved the study protocol. Informed consent was obtained
from each patient or next of kin.
Statistical analysis
Results are expressed as means ± SD for variables that puta-
tively exhibited a normal distribution. On rejection of the nor-
mality hypothesis or for ordinal variables, we used the median
and interquartile range (IQR). Student's t-test for independent
groups was applied to data with a normal distribution. When
normality was rejected or ordinal variables were involved, the
Mann–Whitney U-test was used for independent groups. For
categorical variables the Pearson χ2 test or Fisher's exact test
was applied as appropriate. Survival probabilities were esti-
mated with the product-limit method (Kaplan–Meier algo-
rithm). The log-rank test was used to compare patient survivals
in different groups. All analyses were two-tailed. A 95% confi-
dence interval (CI) was used for the incidence rates. Statistical
significance was recognized at P < 0.05. The statistical anal-
ysis was performed with the Minitab software package for
Windows (release 13.1, Minitab Inc., State College, PA, USA).
Results
General overview
There were five participating ICUs from two different States of
Brazil. The mean monthly hospital admissions average about
190,000 for São Paulo State and 32,000 for Santa Catarina
State (data from Ministry of Health; http://www.data
sus.gov.br). Hospital and demographic characteristics of the
participating centers are shown in Table 1. During the period
from 21 May 2001 to 31 January 2002, 1688 patients were
admitted to the ICUs of the participating centers. Of these,
132 (7.8%) were excluded and 173 (10.2%) were missed.
The total number of enrolled patients was therefore 1383
(81.9%). Of these, 884 (63.9%) had an ICU LOS longer than
24 hours, and 499 (36.1%) had an ICU LOS less than 24
hours. Figure 1 depicts the whole process of patient screening
and their respective mortality rates in accordance with Con-
sensus Conference categories.
Groups for LOS
For the whole cohort (n = 1383), the median age was 65.2
years (IQR 49–76); 700 (58.7%) were males, the median ICU
Figure 1
Flow diagram of enrolled patients and their mortality rate according to  Consensus Conference categories Flow diagram of enrolled patients and their mortality rate according to 
Consensus Conference categories. ICU, intensive care unit; SIRS, sys-
temic inflammatory response syndrome.
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LOS was 2 days (1–6), and the overall 28-day mortality rate
was 21.8%. The main ICU admission diagnoses were as
follows: lung/respiratory tract infection (8.5%), acute coronary
syndrome (7.2%), gastrointestinal surgery (6.0%), sepsis
(5.2%), cardiovascular surgery (4.6%), gastrointestinal sur-
gery for malignancy (4.6%) and clinical neurological disorders
(4.1%).
For the 1383 patients, the incidence density of sepsis was
57.9 (95% CI 51.5–65.3) per 1000 patient-days or 421 epi-
sodes of sepsis, corresponding to 30.5 (28.9–32.1) per 100
screened ICU admissions. In the same population, there were
241 episodes of severe sepsis and 203 episodes of septic
shock, corresponding to 17.4 (16.5–18.6) and 14.7 (13.9–
15.5) per 100 screened ICU admissions. For patients who
stayed less than 24 hours in ICU, the median age was 64
years (48–74), 57.6% were male, main admission diagnoses
were similar to those of the whole group, and 20.8% of them
died.
A total of 884 patients with an ICU LOS longer than 24 hours
were enrolled in all participating centers. The median age was
66.4 years (IQR 49.2–77.1), 522 (59%) were males, median
ICU LOS was 4 days (2–9), median APACHE II score was 17
(11–22), median SOFA score on the first day was 4 (2–8) and
the overall 28-day mortality rate was 22.3%. The main ICU
admission diagnoses were as follows: lung/respiratory tract
infection (13.9%), acute coronary syndrome (12%), gastroin-
testinal surgery (9.3%), sepsis (7.8%), gastrointestinal surgery
for malignancy (7.0%), post-surgical cardiovascular vigilance
(6.9%) and clinical neurological disorders (6.4%). Several
other admission diagnostic categories, each amounting to less
than 6% of enrolled patients, accounted for the remaining
30.9% of diagnoses (Table 2).
Patients with SIRS, sepsis, severe sepsis and septic 
shock
Of 884 patients with an ICU LOS of more than 24 hours, 785
(88.8%) met SIRS criteria in at least 1 day during their ICU
stay. In the same direction, sepsis criteria were fulfilled in 415
(46.9%), severe sepsis in 241 (27.3%) and septic shock in
203 (23%) patients. It is noteworthy that the same patient
could be classified in more than one category if he or she ful-
filled the criteria, because these categories represent evolving
stages of the same process. The incidence density rates for
sepsis, severe sepsis and septic shock were 61.4 (95% CI
55.5–67.3), 35.6 (31.1–40.1) and 30.0 (25.9–31.4) per
1000 patient-days, respectively. The mortality rates of patients
with SIRS, sepsis, severe sepsis and septic shock were
24.2%, 33.9%, 46.9% and 52.2%, respectively (Fig. 2). For
patients with SIRS without infection the mortality rate was
11.3%.
For a better understanding of the relationship between ACCP/
SCCM definitions and outcome, we calculated the first-day
SOFA score for each category. The median scores were 3
(IQR 1–5.2), 4 (3–6), 7.5 (5–10) and 8 (6–11) for SIRS, sep-
sis, severe sepsis and septic shock, respectively. Among sep-
tic patients (n = 415), the medians of the maximum SOFA
scores for each category were 5.0 (4–7), 8.8 (7–11), 11.0 (9–
13) for sepsis, severe sepsis and septic shock, respectively.
There was a significant positive correlation between the maxi-
mum SOFA score and each category (rs = 0.72, P < 0.0005).
Sepsis was diagnosed in 415 patients during their ICU stay,
with 281 (67.7%) meeting sepsis diagnostic criteria on admis-
sion and 134 (32.3%) on the following days. Among patients
with sepsis diagnosed after admission to ICU, the main pri-
mary admission diagnoses were as follows: neurological dis-
orders (20.1%), head trauma (14.2%), gastrointestinal surgery
(13.4%) and lung/respiratory tract infection (8.2%). For all
septic patients, the source of infection in each septic episode
was lung/respiratory tract in 65.6%, urinary tract in 5.6%,
abdomen/surgical wound in 4.9%, bloodstream in 2.5%, and
other/unknown sites in 21.4%.
Septic versus nonseptic patients
We prospectively divided the patients with an ICU LOS of
more than 24 hours into septic and nonseptic groups. The
median ages were similar for septic (66.2 years [IQR 48.2–
78.3]) and nonseptic (66.4 years [50–76]) patients, respec-
tively. The median APACHE II score was higher in septic
patients (19 [14-24]) than in nonseptic patients (15 [10-19])
(P < 0.0005).
We assessed the SOFA scores for all patients to identify the
severity of organ dysfunction in septic and nonseptic patients.
The median SOFA score on the first sepsis day (or admission
day for nonseptic patients) was higher in septic patients (6
[IQR 4–9]) than in nonseptic patients (3 [1-5]) (P < 0.0005).
In addition, survivors in both groups had significantly lower
SOFA scores than non-survivors.
However, some chronic diseases were more prevalent in sep-
tic patients, such as congestive heart failure (4.1% versus
1.5%; P < 0.05), malignancy (18.3% versus 12.1%; P < 0.05)
and chronic obstructive pulmonary disease (14.0% versus
9.4%; P < 0.05). Hypertension (38.1% versus 38.6%), diabe-
tes mellitus (21.7% versus 22.2%), chronic renal failure (7.5%
versus 6.8%) and liver cirrhosis (4.3% versus 2.9%) were
equally distributed between the two groups. Finally, Fig. 3
depicts the 28-day Kaplan–Meyer survival curve of septic and
nonseptic patients, showing the impact of a septic episode on
their outcome. The 28-day survival rates were 66% and 88%
for the septic and nonseptic groups, respectively (P < 0.001).
Private versus public hospitals
The median age was higher for patients from the private hos-
pital (73.6 [IQR 58.5–81.5]) than for those from public hospi-
tals (60.9 [44.7–72.2]) (P < 0.0005). There was no differenceCritical Care    August 2004  Vol 8 No 4    Silva et al.
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Table 2
Clinical and infectious characteristics of all patients with an ICU LOS of more than24 hours
Characteristic Center 1 Center 2 Center 3 Center 4 Center 5 Total
Enrolled patients (n) 359 146 125 76 178 884
Median age (IQR) 73.6 (58.5–81.5) 55.4 (42.5–60.6) 47.6 (32.0–66.9) 61.4 (44.2–68.7) 68.9 (57.8–77.1) 66.4 (49.2–77.1)
Male/female (%) 62/38 59/41 59/41 62/38 51/49 59/41
Median APACHE II 
score (IQR)
16 (11–21) 17.5 (9.7–25.2) 16 (12–20) 16 (10–20) 18 (14–21) 17 (11–22)
First-day SOFA score 
(IQR)
3 (1–5) 6 (2.7–9) 6 (3–8) 4 (2–7) 6 (4–9) 4 (2–8)
Median ICU LOS, days 
(IQR)
3 (2–7) 5.5 (3–10.2) 6 (3–12) 3 (2–7.7) 4 (2–10) 4 (2–9)
Main ICU admission 
diagnosis
Respiratory infection, 
n (%)
43 (11.9) 16 (10.9) 10 (8.0) 12 (15.8) 42 (23.6) 123 (13.9)
Acute coronary 
syndrome, n (%)
52 (14.5) 24 (16.4) 4 (3.2) 25 (32.9) 2 (1.1) 107 (12.0)
GI postoperative 
patients, n (%)
9 (2.5) 11 (7.5) 5 (4.0) 7 (9.2) 50 (28.1) 82 (9.3)
Sepsis, n (%) 34 (9.5) 2 (1.4) 17 (13.6) 3 (3.9) 13 (7.3) 69 (7.8)
GI surgery for 
neoplasm, n (%)
22 (6.1) 4 (2.7) 4 (3.2) 7 (9.2) 25 (14.0) 62 (7.0)
Cardiovascular 
surgery, n (%)
38 (10.6) 1 (0.06) 4 (3.2) - 18 (10.1) 61 (6.9)
Clinical neurological 
disorders, n (%)
36 (10.0) 10 (6.8) 6 (4.8) - 5 (02.8) 57 (6.4)
Site of infection
Lung, n (%) 86 (72.3) 30 (43.5) 52 (67.5) 24 (68.5) 75 (70.1) 267 (65.6)
Urinary tract, n (%) 9 (7.6) 4 (5.7) 5 (6.5) - 5 (4.7) 23 (5.6)
Abdomen/surgical 
wound, n (%)
4 (3.3) 5 (7.3) - 5 (14.3) 6 (5.6) 20 (4.9)
Bloodstream, n (%) 5 (4.2) 1 (1.5) 1 (1.3) 3 (8.6) 21 (19.6) 10 (2.5)
Other/unknown,
n (%)
15 (12.6) 29 (42.2) 19 (24.7) 3 (8.6) 21 (19.6) 87 (21.4)
Diagnosed 
infections, n (%)
119 (100) 69 (100) 77 (100) 35 (100) 107 (100) 407 (100)
Enrolled patients, n
Consensus 
Conference 
Diagnosis
359 146 125 76 178 884 (100%)
SIRS 291 130 122 74 168 785 (88.8%)
Sepsis 121 72 79 34 109 415 (46.9%)
Severe sepsis 57 38 46 191 81 241 (27.3%)
S e p t i c  s h o c k 4 23 43 91 67 22 0 3  ( 2 3 . 0 % )
Overall mortality rate 
(%)
12.5 32.2 23.7 24.8 31.4 22.3
GI, gastrointestinal; IQR, interquartile range; LOS, length of stay; SIRS, systemic inflammatory response syndrome; SOFA, sequential organ 
failure assessment.Available online http://ccforum.com/content/8/4/R251
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in median first-day APACHE II score between patients from
the private hospital (16 [11-21]) and those from public hospi-
tals (17 [12-22]) (P < 0.0005). The median first-day SOFA
score was lower for patients from the private hospital (3 [1-5])
than for those from public hospitals (6 [3–8.5]) (P < 0.0005).
The overall mortality rate was lower for patients from the
private hospital than for those from public hospitals (12.5%
versus 28.9%; P < 0.0005).
In comparison with the other centers, the private hospital had
47.3% versus 38.1% patients with SIRS, 18.4% versus
20.9% with sepsis, 15.3% versus 35% with severe sepsis and
11.7% versus 30.7% with septic shock. The 28-day mortality
rates for SIRS, sepsis, severe sepsis and septic shock
patients in the private hospital and the other centers were,
respectively, 8.8% versus 17.5%, 16.7% versus 15.4%,
32.7% versus 51.6% (P = 0.08) and 33.3% versus 57.1% (P
= 0.006). Because mortality rate for septic shock was greatly
different between the private and public hospitals we also cal-
culated a first-day SOFA score for these patients. For 'private'
septic shock patients the score was 8 (IQR 4–10), whereas
for 'public' septic shock patients it was 9 (6–11) (P = 0.085.
Discussion
This is the first prospective cohort epidemiological study of
sepsis performed in Brazil, the largest country in South Amer-
ica, and to our knowledge it is the first large cohort of this kind
performed in an underdeveloped country. Brazil is heterogene-
ous in many aspects such as income distribution, educational
profiles and use of technology. Even within a particular State,
those characteristics can vary significantly. We have initially
included five ICUs belonging to the recently created Brazilian
Critical Care Clinical Trials Network, because these ICUs
already have all personnel and infrastructure for the study. A
second phase of our BASES study has already been started
in five other ICUs. We have therefore prospectively included
1383 patients admitted to five mixed ICUs from São Paulo and
Santa Catarina States, and followed all of them daily, search-
ing for the ACCP/SCCM criteria of SIRS, sepsis, severe sep-
sis and septic shock, and also for organ dysfunction
development (SOFA score). This study design allowed the
identification of septic episodes at admission and those begin-
ning during the course of ICU stay. This information can be
used to identify risk factors associated with sepsis in patients
admitted to the ICU without infection, and also to verify
differences in outcome for patients admitted with and without
infection.
In general, we found a higher incidence density for sepsis,
severe sepsis and septic shock than those reported by other
studies [13,14]; this could have been due to a more severely
ill cohort of patients, resulting in a greater proportional use of
invasive devices such as central venous lines, urinary
catheters and mechanical ventilation. In addition, our patients
had a higher LOS in ICU. Different types of hospital (teaching
versus non-teaching), types of ICU (mixed versus surgical),
antibiotic use patterns and frequency of antimicrobial-resistant
pathogens might also have been factors.
In comparison with the classical study of Rangel-Frausto [10],
we have found a higher severe sepsis occurrence rate (27.3%
versus 11.5%), which could be ascribed to the organ dysfunc-
tion criteria used in our study and to the fact that we did not
enroll ward patients. We defined severe sepsis as any patient
with at least one organ dysfunction identified by the SOFA
score. In another prospective study, Sands and colleagues
[13] documented an incidence density of sepsis of 2.8 ± 0.17
Figure 2
Overall mortality rate and sepsis-related mortality rate according to  American College of Chest Physicians/Society of Critical Care Medi- cine Consensus Conference definitions Overall mortality rate and sepsis-related mortality rate according to 
American College of Chest Physicians/Society of Critical Care Medi-
cine Consensus Conference definitions. A progressively higher mortal-
ity was observed as systemic inflammatory response syndrome (SIRS) 
was due to infection, namely sepsis, and as more severe organ dysfunc-
tions were present, namely severe sepsis and septic shock. The first 
column shows mortality from the group of patients who met SIRS crite-
ria but who had no infection; in that case there was no sepsis-related 
death.
Figure 3
Kaplan–Meier survival curve for intensive care unit admissions with sep- sis and without sepsis Kaplan–Meier survival curve for intensive care unit admissions with sep-
sis and without sepsis.Critical Care    August 2004  Vol 8 No 4    Silva et al.
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per 1000 patient-days. This study also included ICU and ward
patients. Even in a study that followed only ICU patients [15],
the occurrence rate of clinically suspected sepsis and con-
firmed severe sepsis was 9.0% and 6.3% of ICU admissions,
respectively. In contrast and despite the smaller number of
patients in our cohort, we have found a similar occurrence rate
of severe sepsis (27.3%) to that found in the larger study of
Alberti and colleagues (22.7%) [6]. This is important for vali-
dation of our data. It is noteworthy that both studies included
only ICU patients.
There has been great variability in outcome reported in several
studies in septic patients. In 1998, Friedman and colleagues
published data from 131 studies [4] involving only septic
shock patients. In that study they found a mortality rate of
about 50%, with no major change in the previous 20 years.
Other studies [10,13,16] reported mortality rates for severe
sepsis and septic shock patients ranging from 20% to 81%.
One of the major challenges in sepsis studies is to standardize
the enrolled population to allow adequate comparison, princi-
pally in epidemiologic and therapeutic trials. The severe sepsis
mortality rate in our study was similar to those in studies that
used the same (ACCP/SCCM Consensus) criteria [6,16,17],
but was higher than those found by Rangel-Frausto and col-
leagues [10] and Angus and colleagues [5]. Many factors can
explain those differences, for example patient age, associated
comorbidities and severity of s e p s i s  ( A P A C H E  I I  s c o r e ) ,
source and type of infection (community, nosocomial or ICU-
acquired), and number and severity of organ dysfunctions. In
addition, we must consider access to the best standard of
care [18], which can easily be appraised from the outcomes of
private versus public hospitals in our cohort.
Although the ACCP/SCCM Consensus Conference definition
categories have received severe criticisms, some authors
[10,16] have found a close relationship between these cate-
gories and outcome. This relationship could be explained by
the organ dysfunction presence implicit in this categorization.
Thus, to clarify this matter, we measured the SOFA score daily
and observed that as the sepsis-related conditions increased
from sepsis to septic shock, the first-day and maximum SOFA
scores also increased in parallel. This probably suggests that
when using the ACCP/SCCM definitions it would be very use-
ful to measure organ dysfunction by means of an organ dys-
function descriptor, to improve the characterization of the
progress of the septic patient in ICU.
The lungs and respiratory tract was the main source of infec-
tion in our group of septic patients. This finding has been
reported by others [6,19] and highlights the major role of res-
piratory infection in ICUs and the need for its prevention. Many
of these episodes have been related to ventilator-associated
pneumonia [20,21]. In our study, the diagnosis of community-
acquired or nosocomial respiratory infection was made on the
basis of clinical, laboratory and radiographic data. We did not
routinely use any kind of tool-based diagnosis, such as pro-
tected brush-specimen or broncho-alveolar lavage. The high
incidence of lung/respiratory infection in our study might there-
fore be due, at least in part, to the broad definition criteria we
used.
Variability in the time course of sepsis can introduce difficulties
in case definition and might consequently explain some dis-
crepancies in incidence rates between studies. In our study,
sepsis was diagnosed in 415 patients during their ICU stay,
with 281 (67.7%) meeting sepsis diagnostic criteria on admis-
sion and 134 (32.3%) on the following days. Similarly, Knaus
and colleagues [22] found that 18% of patients did not meet
case definition criteria for sepsis at the time of admission but
did meet them within the first week of ICU stay. It is therefore
very important to be aware of the case definition criteria used
in each study, because the incidence of sepsis can vary
according to the follow-up period.
The impact of sepsis in critically ill patients has been underes-
timated by governmental health services. Quartin and col-
leagues [23] showed in their large study that sepsis could
jeopardize patients for up to 5 years after a septic episode. In
addition, in their model they evaluated the impact of sepsis and
common associated comorbidities. They generated a model of
how comorbidities could affect survival by studying a large
cohort of nonseptic patients. Application of this model to the
septic population yielded a prediction of death rates from
causes other than sepsis, and mortality beyond this prediction
was considered 'sepsis-associated'. They found that although
septic patients have many associated comorbidities, sepsis is
the cause of many deaths that occur outside the time frame
normally associated with this acute disease. In our population,
we found that septic patients had higher APACHE II and
SOFA scores and a similar number of comorbidities, but
higher rates of malignancy, congestive heart failure and
chronic obstructive pulmonary disease. Actually, septic
patients have severe acute physiological disturbances, as
shown by the SOFA score, and probably have chronic dis-
eases, as shown by the APACHE II score, decreasing the pos-
sibility of a more rapid recovery free of sequels. In general,
acute organ dysfunction is related to early outcome and asso-
ciated comorbidities are related to late outcome. However,
this apparent acute disease could interfere long after its iden-
tification. It is therefore possible that septic patients suffer tis-
sue organ derangements leading to prolonged occult risks for
mortality. Although this interesting hypothesis has not yet been
explored, recent clinical trials in sepsis [2,24,25] have
included long-term follow-up.
When comparing data from the private hospital with those
from the public hospitals (Table 3), we found an incidence of
severe sepsis of 16% versus 35%. This difference can be
explained by a higher incidence of infection in public hospitals,
where patients have a poorer nutritional status and are admit-Available online http://ccforum.com/content/8/4/R251
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ted later in the course of their disease to the ICU. Frequently,
studies from developed countries correlate the incidence of
severe sepsis with more advanced age and a greater number
of underlying diseases and invasive procedures [15]. Although
the private hospital presented all these factors in our study, it
showed an incidence of severe sepsis similar to that reported
in the literature and lower than that for the public hospitals. We
suggest that in Brazil, social and economical factors have a
greater influence on the incidence of infection than those clas-
sically demonstrated factors. In addition, among septic shock
patients we also observed a higher mortality rate in the public
hospitals, although the first-day SOFA scores were similar in
both groups, namely private and public hospitals. Factors
including care provided by the hospitals, delay between hos-
pital (emergency room) and ICU admissions, quality of the mul-
tiprofessional ICU team, and access to the best standard of
care could explain those discrepant mortality rates. Neverthe-
less, these data need to be confirmed by specifically designed
trials, because we had data from only one private hospital and
it could be an outlier institution. Caution should therefore be
exercised before drawing definitive conclusions.
In conclusion, sepsis is an emergent public health problem
with a high incidence density and high mortality rates. In our
study, the incidence density of sepsis was about 57 per 1000
patient-days, with a high overall mortality rate and a sharp con-
trast between private and public hospitals. Moreover, there
was a close relationship between ACCP/SCCM categories,
organ dysfunction development and mortality rate.
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